被 发 现 含 有 未 标 示 西 药 的 产 品
|
| |
| Australia: Safety advisory: Deli by New Queen capsules contain the undeclared substance sibutramine (English Only) |
| |
The Therapeutic Goods Administration (TGA) has tested a product labelled Deli by New Queen capsules and found that the capsules contain the undeclared substance sibutramine. Consumers are advised that sibutramine is a prescription-only medicine in Australia (which was the active ingredient in Reductil). It was withdrawn in October 2010 after a study showed an increased risk of major cardiac events. The supply of Deli by New Queen capsules containing undisclosed sibutramine is illegal. Deli by New Queen capsules have not been assessed by the TGA for quality, safety or efficacy as required under Australian legislation, and the place of manufacture is not approved by the TGA. Consumers are advised to stop taking the product and take any remaining capsules to their local pharmacy for safe disposal. If they have any concerns arising from their use of this product, consult their health care practitioner.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/alert/deli-new-queen-capsules
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/ Saturday, Feb 23, 2019
Issued at HKT 12:00
|
| |
